Motif Neurotech, a company specialising in bioelectronics for mental health, has raised $18.75m in a series A funding round. The money will be used to advance clinical development of its DOT microstimulator, a device designed to treat treatment-resistant depression (TRD) by stimulating specific brain circuits. The funding will also help the company enhance the device, scale production and distribution.
NSO permanently barred from targeting WhatsApp users with Pegasus spyware
A federal judge has ordered spyware maker NSO to stop using its Pegasus app to target or infect users of WhatsApp. The ruling, issued Friday
